echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Important pharmaceutical policies will be pushed aside to affect all pharmaceutical companies

    Important pharmaceutical policies will be pushed aside to affect all pharmaceutical companies

    • Last Update: 2020-11-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Up to now, the centralized procurement of drugs organized by the state to the third batch, the trend of normalization of collection and harvesting appears.
    , according to relevant government documents, the next stage of health care payment reform or become a key content.
    evening of March 5, the Central Committee of the Communist Party of China and the State Council issued the Opinions on Deepening the Reform of the Health Care System, which made it clear that the reform of the payment method for medical insurance will continue to be promoted.
    " vigorously promote the application of big data, the implementation of a multi-composite medical insurance payment method based on disease-based payment, the promotion of disease diagnosis-related group payment, medical rehabilitation, chronic mental illness and other long-term hospitalization pay by bed day, outpatient special chronic diseases pay by head."
    There are industry experts today to Seber blue said that the effect of the national organization of drug collection is mainly generic drugs to reduce prices significantly, to achieve the original drug replacement, improve the concentration of the pharmaceutical industry, squeeze out the drug belt gold sales space, promote the transformation and upgrading of enterprises, save medical insurance funds.
    The reform of the payment method of medical insurance based on the payment by disease is mainly changed from the post-payment system to the prepaid system, through the way of packaging pre-payment according to the disease, according to the different payment standards determined by different diseases, the implementation of the policy of savings and retention, overspending and reasonable sharing, forcing hospitals, doctors to use drugs rationally, reasonable diagnosis and treatment, saving medical resources, improving the quality of medical services and so on.
    , on July 15th, the Shanghai Municipal Health and Health Commission issued the Shanghai Key Action Plan for Deepening Medical Reform (2020-2022), which plans the focus of Shanghai's medical reform for the next two years.
    As a city that undertakes the procurement of centralized drug volume organized by the state, Shanghai said it will encourage public medical institutions to conduct centralized bargaining procurement of drugs with volume and budget in the form of medical associations, monos or voluntary procurement alliances for drugs not included in centralized belt procurement.
    clearly defined in the Action Plan is to steadily implement the big data disease cost-es charge and DRG-paid pilot, and to expand the scope of the pilot in an orderly manner.
    to 2022, on the basis of the Shanghai pilot, the "four-in-one" (DRG, big data diseases, pay-per-bed, pay-per-head) multi-composite health insurance payment model under the total budget framework will be fully implemented.
    , Hebei Health and Health Commission in a notice to deepen medical reform also made it clear that it will vigorously promote pay-per-disease, actively promote pay-per-bed, start simulation operation in 2020, start actual payment in 2021.
    is based on the "three-step" step of the DRG pay country pilot: 2019 is the DRG top-level design phase, 2020 is the simulation operation phase, 2021 is the actual payment phase.
    overall, the two years to come in 2021 and 2022 will be an important period for the overhaul of health care payment methods, and for pharmaceutical companies, the impact of health care payment method reform should also be anticipated.
    large prescriptions, disorderly drug use or become the history of Fujian Sanming as a national medical reform star demonstration city, from 2016 to date, began to implement medical insurance package payment as the starting point, the construction of regional health care organizations, and strive to provide the masses with a full range of full-cycle health and health services.
    before the reform of health care payment methods, Sanming went through two stages: the treatment of chaos, the blocking of waste (2012.2-2013.1) and the establishment of regulations and the establishment of a system (2013.2-2016.8).
    In the first stage, Sanming implemented the key drug monitoring, control the circulation of drug prices, regulate medical behavior and other measures, in the second stage, Sanming began to break the rules and regulations, straighten out the government management system, establish the "three-doctor linkage", "two-vote system", "annual salary system", "three insurance and one" and other reforms of the "four pillars and eight pillars."
    June 2017, the former General Office of the State Health and Planning Commission issued a Notice on the Implementation of the Pilot Work on The Collection and Payment Reform by Group Related to Disease Diagnosis, announcing that the C-DRG Collection Reform Pilot Work was officially launched in Shenzhen, Sanming and Kramay.
    's C-DRG pay-per-view reform will enter its official operational phase on January 1, 2018.
    , Sanming's health care payment method reform has achieved remarkable results.
    Sanming City Health Reform Leading Group Secretariat Deputy Director, Sanming City Health Care Commission four-level researcher Zhou Xianxuan said, unlike the original project-based payment, income and service number linked, hospitals in pursuit of economic benefits, easy to cause excessive use of medical services, in the total cost control, and pay-per-disease-based multi-health insurance payment method reform, medical costs significantly decreased, hospital revenue increased, unreasonable drug use and treatment significantly reduced.
    The above-mentioned person said to Seberan, Sanming to implement the reform of the payment method of health insurance has a better basis for reform - first, through the integration of the "three insurance", joint price-limiting procurement and other series of measures to reduce the price of drugs (supplies) to a certain level;
    in the exchange with Seberan, the above-mentioned people further said that in the process of implementing the medical reform policy, the effective implementation of policies such as lowering drug prices is an important prerequisite for the reform of the payment method of medical insurance based on the payment of diseases.
    In addition, prior to the implementation of pay-per-disease, it is necessary to determine the payment standards for major diseases, change the concept from leadership to medical personnel, train medical personnel to master relevant knowledge, code drug supplies, medical services, rebuild the home page of hospital medical records, medical insurance payment system, electronic medical record system, etc., to provide information system support for the formal implementation of DRG.
    In the process of paying by disease, the examination, examination, medicine and sanitary materials (including high-value consumables and low-value consumables) used by in-patient patients need to be included in the pricing by disease group, in the process, drugs that do not conform to clinical pathways and do not have clear clinical value and efficacy will undoubtedly be excluded from packaging.
    Practice shows that the implementation of DRG is conducive to higher-level hospitals to take the initiative to transfer common diseases to the grass-roots level, to achieve graded diagnosis and treatment;
    Further, the implementation of DRG can effectively regulate the behavior of diagnosis and treatment services - breaking by medicine, excessive medical behavior, strengthening the use of drugs and consumables;
    In general, under this payment method, is based on value of medical treatment, to pay for the value of the traditional "to supplement medicine, to supplement medicine with materials, to check medical treatment" era is gone.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.